Clonidine: Difference between revisions
Appearance
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) Remove Category:Psychostimulants tag (second pass after duplicate-tag situation) |
MDElliottMD (talk | contribs) Tier 2 taxonomy consolidation: Category:Alpha-2 Agonists (for ADHD) -> Category:Alpha-2 Adrenergic Agonists; remove Category:Alpha-2 agonists for withdrawal |
||
| Line 32: | Line 32: | ||
[[Category:Alpha-2 Agonists | [[Category:Alpha-2 Adrenergic Agonists]] | ||
[[Category:Addiction Medicine]] | [[Category:Addiction Medicine]] | ||
Revision as of 18:28, 21 May 2026
Alpha-2 agonist, ADHD medicine
Clonidine
Kapvay
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
Pharmacogenomic + mechanism interactions
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
FDA Drug Interactions Table: transporter inhibitor (SLC22A2).
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Clonidine inhibits SLC22A2 (inhibitor, intensity 70); Metformin is a substrate of SLC22A2 (intensity 70). Derived: Metformin exposure raised.
Inferred via Enzyme:SLC22A2 (exposure raised)
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Confidence in this inference: is the inferred magnitude sound?overstatedsound
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
Patient experience
No patient-experience reports yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Alpha-2 agonist, ADHD medicine
Common uses
Pharmacy
Pharmacology
Purported mechanism
Alpha-2 adrenergic receptor agonist